Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K

Many pharmaceutical agents not only require microbial metabolism for increased bioavailability and bioactivity, but also have direct effects on gut microbial assemblage and function. We examined the possibility that these actions are not mutually exclusive and may be mutually reinforcing in ways tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasebe, Takumu, Ueno, Nobuhiro, Musch, Mark W., Nadimpalli, Anuradha, Kaneko, Atsushi, Kaifuchi, Noriko, Watanabe, Junko, Yamamoto, Masahiro, Kono, Toru, Inaba, Yuhei, Fujiya, Mikihiro, Kohgo, Yutaka, Chang, Eugene B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777267/
https://www.ncbi.nlm.nih.gov/pubmed/26977303
http://dx.doi.org/10.1002/prp2.215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777267/
https://www.ncbi.nlm.nih.gov/pubmed/26977303
http://dx.doi.org/10.1002/prp2.215

Ejemplares similares